Technavio
Announces the Publication of its Research Report Global In-vitro DiagnosticsInstruments Market 2016-2020
Technavio recognizes the following companies as the key players in the global in-vitro diagnostics market: Abbott Laboratories, Danaher, Siemens Healthcare, Roche Diagnostics, and Thermo Fisher Scientific
Other Prominent Vendors in the market are: A&T, A. Menarini Diagnostics, Abaxis, Abcam, Accriva Diagnostics, Acon Laboratories, Affymetrix, Ahram Biosystem, ARKRAY, AsuraGen, Biocartis, Bio-Rad Laboratories, CellaVision, Cepheid, Chembio Diagnostic Systems, Chembio Diagnostic Systems, Clarity Diagnostics, Corgenix, DiagCor, Drucker Diagnostics, EKF Molecular Diagnostics, Erba Diagnostics, GREEN CROSS MEDIS, Helena Laboratories, Hologic, HORIBA, Instrumentation Laboratory, i-Sens, Landwind Medical, Mindray, Nihon Kohden, Nipro Diagnostics, Randox Laboratories, Sekisui Medical, Sienco, Sinduri Biotec, Snibe Diagnostics, Stago, and Trivitron Healthcare
Commenting on the report, an analyst from Technavio’s team said: “The POL test segments are related to actionable infectious disease markers, cardiovascular diseases, and diabetes care. Most common infectious disease testing has enabled the usage of molecular diagnostic instruments in the POL practice. Many instruments that are usually used for testing in the central labs, now support the testing in POL. While CLIA testing for such molecular assays would increase its market growth, certain regulatory aspects over CLIA-waived test would likely delay its market growth.”
Technavio recognizes the following companies as the key players in the global in-vitro diagnostics market: Abbott Laboratories, Danaher, Siemens Healthcare, Roche Diagnostics, and Thermo Fisher Scientific
Other Prominent Vendors in the market are: A&T, A. Menarini Diagnostics, Abaxis, Abcam, Accriva Diagnostics, Acon Laboratories, Affymetrix, Ahram Biosystem, ARKRAY, AsuraGen, Biocartis, Bio-Rad Laboratories, CellaVision, Cepheid, Chembio Diagnostic Systems, Chembio Diagnostic Systems, Clarity Diagnostics, Corgenix, DiagCor, Drucker Diagnostics, EKF Molecular Diagnostics, Erba Diagnostics, GREEN CROSS MEDIS, Helena Laboratories, Hologic, HORIBA, Instrumentation Laboratory, i-Sens, Landwind Medical, Mindray, Nihon Kohden, Nipro Diagnostics, Randox Laboratories, Sekisui Medical, Sienco, Sinduri Biotec, Snibe Diagnostics, Stago, and Trivitron Healthcare
Commenting on the report, an analyst from Technavio’s team said: “The POL test segments are related to actionable infectious disease markers, cardiovascular diseases, and diabetes care. Most common infectious disease testing has enabled the usage of molecular diagnostic instruments in the POL practice. Many instruments that are usually used for testing in the central labs, now support the testing in POL. While CLIA testing for such molecular assays would increase its market growth, certain regulatory aspects over CLIA-waived test would likely delay its market growth.”
According to
the report, POCT testing for cardiovascular biomarkers is a strategic IVD focus
area even for non-traditional healthcare companies. In 2011, Samsung
Electronics acquired Nexus Dx, a developer of rapid POC tests for diagnosing
cardiovascular disease. Loss of employer sponsored health plans due to
unemployment drove many Americans to seek other ways of receiving routine
healthcare. Retail clinics, pharmacies, and home care settings have gained
popularity because of added conveniences.
Further, the report states that IVD industry consolidation intensified since 2012. Crucial deals in 2012 include Hologic’s acquisition of Gen-Probe and Life Technologies’ acquisition of Navigenics, a genetic testing laboratory. The other notable consolidation includes larger company like Agilent) with considerable resources and has increased the ability for the acquiring company to compete and control market dynamics in its favor. This is threatening the market entry of small companies.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Get discount: https://marketreportscenter.com/request-discount/470058
Further, the report states that IVD industry consolidation intensified since 2012. Crucial deals in 2012 include Hologic’s acquisition of Gen-Probe and Life Technologies’ acquisition of Navigenics, a genetic testing laboratory. The other notable consolidation includes larger company like Agilent) with considerable resources and has increased the ability for the acquiring company to compete and control market dynamics in its favor. This is threatening the market entry of small companies.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Get discount: https://marketreportscenter.com/request-discount/470058
About In-vitro Diagnostics Instruments
The global IVD instruments market is expected to grow at a steady rate during the forecast period. The factors like increasing older population, rise in incidence and prevalence of chronic diseases and infections are driving the market. Cancer, tuberculosis, malaria, diabetes, and cardiovascular diseases are the main factors for the rise in diagnosed population. In addition, increasing public awareness, rapid technological innovations, product approvals from regulatory authorities and launches are expected to positively influence the market growth over the next few years.
Technavio’s analysts forecast the global in-vitro diagnostics instruments market to grow at a CAGR of 9.73% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global in-vitro diagnostics instruments market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of IVD instruments.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global In-vitro Diagnostics Instruments Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Abbott Laboratories
• Danaher
• Roche Diagnostics
• Siemens Healthcare
• Thermo Fisher Scientific
Other prominent vendors
• A&T
• A. Menarini Diagnostics
• Abaxis
• Abcam
• Accriva Diagnostics
• Acon Laboratories
•
• Affymetrix
• Ahram Biosystem
• ARKRAY
• AsuraGen
• Biocartis
• Bio-Rad Laboratories
• CellaVision
• Cepheid
•
• Chembio Diagnostic Systems
• Chembio Diagnostic Systems
• Clarity Diagnostics
• Corgenix
• DiagCor
• Drucker Diagnostics
• EKF Molecular Diagnostics
• Erba Diagnostics
• GREEN CROSS MEDIS
• Helena Laboratories
• Hologic
• HORIBA
• Instrumentation Laboratory
• i-Sens
• Landwind Medical
• Mindray
• Nihon Kohden
• Nipro Diagnostics
• Randox Laboratories
• Sekisui Medical
• Sienco
• Sinduri Biotec
• Snibe Diagnostics
• Stago
• Trivitron Healthcare
Market driver
• High demand for automation and integration of multiple processes driving new product development
• For a full, detailed list, view our report
Market challenge
• Reduction in profits for manufacturers due to the US medical device tax policies
• For a full, detailed list, view our report
Market trend
• Potential opportunities for physician office laboratories (POL)
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
The global IVD instruments market is expected to grow at a steady rate during the forecast period. The factors like increasing older population, rise in incidence and prevalence of chronic diseases and infections are driving the market. Cancer, tuberculosis, malaria, diabetes, and cardiovascular diseases are the main factors for the rise in diagnosed population. In addition, increasing public awareness, rapid technological innovations, product approvals from regulatory authorities and launches are expected to positively influence the market growth over the next few years.
Technavio’s analysts forecast the global in-vitro diagnostics instruments market to grow at a CAGR of 9.73% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global in-vitro diagnostics instruments market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of IVD instruments.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global In-vitro Diagnostics Instruments Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Abbott Laboratories
• Danaher
• Roche Diagnostics
• Siemens Healthcare
• Thermo Fisher Scientific
Other prominent vendors
• A&T
• A. Menarini Diagnostics
• Abaxis
• Abcam
• Accriva Diagnostics
• Acon Laboratories
•
• Affymetrix
• Ahram Biosystem
• ARKRAY
• AsuraGen
• Biocartis
• Bio-Rad Laboratories
• CellaVision
• Cepheid
•
• Chembio Diagnostic Systems
• Chembio Diagnostic Systems
• Clarity Diagnostics
• Corgenix
• DiagCor
• Drucker Diagnostics
• EKF Molecular Diagnostics
• Erba Diagnostics
• GREEN CROSS MEDIS
• Helena Laboratories
• Hologic
• HORIBA
• Instrumentation Laboratory
• i-Sens
• Landwind Medical
• Mindray
• Nihon Kohden
• Nipro Diagnostics
• Randox Laboratories
• Sekisui Medical
• Sienco
• Sinduri Biotec
• Snibe Diagnostics
• Stago
• Trivitron Healthcare
Market driver
• High demand for automation and integration of multiple processes driving new product development
• For a full, detailed list, view our report
Market challenge
• Reduction in profits for manufacturers due to the US medical device tax policies
• For a full, detailed list, view our report
Market trend
• Potential opportunities for physician office laboratories (POL)
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
Table
of content: https://marketreportscenter.com/reports/470058/global-in-vitro-diagnostics-instruments-market-2016-2020#toc
About
Us:
Market Reports Center is an e-commerce
platform obliging the needs of knowledge workers, experts, professionals who
are subject to market research information for their work, or to make strategic
business decisions. Market Reports Center’s team consistently works to update
and extend our existing repository of market research reports by partnering
with new publishers and adding their studies to our website.
Contact us for more details:
Sam
Collins
Market Reports Center
Phone
No: 1-646-883-3044 (US)
No comments:
Post a Comment